All Major Solid Tumors
Cancer Type
Tumor Tissue (FFPE)
Sample Type
10 Working Days
Turnaround Time ¹
ACTOnco®+ analyzes >400 genes and 13 fusion genes to assist physicians identify the most suitable therapies. Treatment evaluations include targeted therapy, immunotherapy, hormone therapy, and chemotherapy.
Precision Medicine to Plan Better Treatment
Every cancer is associated with a unique combination of genomic changes. Furthermore, different cells within a tumor may harbor different genomic abnormalities. Comprehensive genomic profiling can identify such changes in cell signaling pathways by detecting prognostic and predictive biomarkers. This information can then be used to facilitate treatment decisions. This process is known as precision medicine.
Why ACT Genomics?
Humane Process
Avoids multiple biopsies and the time cost associated with single-gene testing, as only a small specimen is required for the simultaneous detection of >400 genes.
Ideal Treatment
Nominates proper targeted options, immunotherapy, chemotherapy, or hormonal therapy.
Smart Budgeting
Evaluates options before treatment, according to genomic information, to ensure success rate and avoid wasting of funds.
Learn More
How to Decide Which Treatment is Better for You?
In life, we may feel regret for a path that was left untaken; however, in cancer treatment, it is important to choose the right path as soon as possible so that there will be no regrets. Although a generic treatment guidance may sometimes provide the correct treatment option, a personalized approach, precision medicine, is much better. The precision medicine approach can assist physicians and patients to confidently navigate the dynamic maze of cancer treatment being directed by genomic mutations, and a study has shown that precision medicine was able to double the percentage of cancer patients who achieved tumor shrinkage. The power of genomics should never be underestimated, as the information contained in the 440 genes associated with cancer has the power to change a patient's life dramatically, as they can identify the right immunotherapy, targeted therapy, chemotherapy or hormonal therapy.
Common Problems Associated with Cancer Treatment
- Chemotherapy and surgery are the only options recommended by the NCCN guidelines or single-gene testing results
- Complications and metastases make it difficult to determine an appropriate drug
- Ineffective treatment and cancer relapse after targeted therapy
- Patients lack understanding in immunotherapy and targeted therapy
Diagnostic Solutions for All Cancers
Through next-generation sequencing (NGS), ACTOnco®+ comprehensive genomic profiling decodes >400 cancer-related genes to map drug options based on thorough clinical research, rather than being limited to a single clinical treatment guideline. ACTOnco®+ is able to determine the growth mechanism on a genomic level to provide more treatment strategy options with a higher success rate. ACTOnco®+ is suitable for ovarian and breast cancers. As single gene testing only provides very limited results, NGS genomic profiling can detect any special genomic mutations to result in a more effective treatment.
Who Is Suitable for ACTOnco®+?
- All major solid tumors
- Newly diagnosed, advanced, recurrent and metastatic cancer
Documentation
Disclaimers / Footnotes
- Turnaround time starts from the date of receipt of approved samples at our CAP-accredited laboratory.
